Skip to the main content

COVID-19 Vaccines and the Case for a New Global Health Diplomacy

Padmashree Gehl Sampath outlines the benefits of global collaboration in the manufacture of the COVID-19 vaccine, as well as the disconnect between availability and access for some of the most vulnerable communities.

A year into the COVID-19 crisis, the virus has exposed and strengthened the global fault lines in healthcare. On the good side, the pandemic brought together governments, pharmaceutical companies, and academic/ research institutes in an unprecedented manner to actively forge new collaborations and produced impressive results..”

Read more

You might also like

Projects & Tools 01

Global Access in Action

Global Access in Action, a project of the Berkman Klein Center for Internet & Society at Harvard University, conducts action-oriented research into access to lifesaving medicines,…